Big Money for Gene Editing, Engineering, Structure-Based Drug Design, and Data Management

Retrieved on: 2021-04-29 04:52:30

Tags for this article:

Click the tags to see associated articles and topics

Big Money for Gene Editing, Engineering, Structure-Based Drug Design, and Data Management. View article details on hiswai:

Excerpt

Benchling, the leading life sciences R&D cloud, has raised $200 million in Series E funding led by Sequoia Capital Global Equities and joined by ...

Article found on: www.bio-itworld.com